19:50 EST eFFECTOR Therapeutics trading halted, news pending
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on EFTR:
- eFFECTOR Therapeutics to Host Virtual Investor R&D Day on January 24, 2024
- eFfector Therapeutics board approves 1-for-25 reverse stock split
- eFFECTOR Therapeutics Announces New Positive Interim Data from Dose Escalation and Phase 2 Expansion Cohorts of Zotatifin in ER+ Metastatic Breast Cancer Patients
- eFfector announces interim data from Phase 2 expansion cohorts of zotatifin
- eFFECTOR Therapeutics receives Fast Track Designation for zotatifin combination